ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
about
ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinomaFree ISG15 triggers an antitumor immune response against breast cancer: a new perspective.Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammationInterferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway.Interferon-stimulated gene 15 in hepatitis B-related liver diseases.Platinum-induced mitochondrial DNA mutations confer lower sensitivity to paclitaxel by impairing tubulin cytoskeletal organization.ISGylation - a key to lock the cell gates for preventing the spread of threats.Cell type-dependent regulation of free ISG15 levels and ISGylation.ISG15: A double edged sword in cancer.ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair.Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer.LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer.miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer.Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases.Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
P2860
Q34148155-740B0D54-1379-451F-B81B-59C47712A6B5Q34483623-1DADAC67-30BE-4C9B-8369-FE1BF6DBD27FQ35740189-363BDB48-A8F7-4473-86E9-701CA843930EQ36069877-A503C788-DE6D-40AC-80CA-FC8AC31449A6Q36305938-EF72DB02-1AE1-4CB4-B248-118E026EE8E8Q37688501-24193494-50C7-4F3F-BE1A-AE9F45C4F38EQ37708705-5B910D2D-79F6-4557-880A-5FAD3133943BQ38795677-0174FAA7-0DA2-458C-84A6-71D1AA491B27Q40079195-1A389CD4-9412-4F7C-846B-11D9CFEE6B43Q41865133-1FEA2B7F-0861-4485-B532-BD8EB184D25CQ42038867-3927560A-771D-4233-A7DE-EE9155DDAB13Q47138566-E8BC3B43-4DEB-4D28-947F-4F53878E6A8EQ47216699-1D8A2CA6-E806-4D2F-AC83-393487891B18Q48159512-91ACC5E6-3570-4911-B4C3-C6DDE9665FFBQ48208504-1ACB2954-8E1D-49A1-AE3B-65C838F28720Q48264888-DDFA3334-92AF-474D-8257-28F5117D6B4EQ49990366-A59BCFBA-AA8A-472D-974B-2286AAF10C1FQ51100814-464DC630-689D-4212-8220-A8DBBC725692Q51119632-E7642874-3B63-4D33-B7F6-CF5C6CDD0F0C
P2860
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@en
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@nl
type
label
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@en
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@nl
prefLabel
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@en
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.633
P407
P577
2013-01-14T00:00:00Z